| Perhexiline |
100 μM |
5 minutes preincubation |
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
193 |
| Amiodarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
| Perhexiline |
200 μM |
5 minutes preincubation |
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
193 |
| Perhexiline |
400 μM |
5 minutes preincubation |
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
193 |
| Perhexiline |
200 μM |
5 minutes preincubation |
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
193 |
| benzarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
| benzbromarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
| benzarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
| Pioglitazone |
|
|
|
|
|
decrease |
Positive |
|
22 |
| benzbromarone |
100 μmol/L |
|
rat; Sprague–Dawley |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
4 |
| clomipramine |
|
|
|
|
|
decrease |
Positive |
|
22 |
| Chlorpromazine |
|
|
|
|
|
decrease |
Positive |
|
22 |
| Sulindac sulfide |
39.8 ± 2.9 |
|
rat |
isolated rat liver mitochondria |
State 3 respiration ( 96-well plate format using a phosphorescent oxygen-sensitive probe MitoXpress) |
inhibit |
Positive |
IC50 (nmol/mg mitochondrial protein) |
40 |
| Miconazole |
I50=100, 160, 160, 170, 150 μM for substrates Glutamate/Malate, Pyruvate/Malate, Ornithine/Malate, Arginine/Malate and Succinate repectively |
|
rat |
liver mitochondria |
Clark electrode |
inhibit |
Positive |
|
303 |
| Metformin |
2mM |
30 minutes |
mouse; C57BL/6J |
isolated skeletal muscle mitochondria |
Measurement of Oxygen level; incubated in complex I substrate; added ADP (500 μM) |
decrease |
Positive |
p < 0.05 |
172 |
| Nitrofurantoin |
1 mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used glutamate as substrate |
decrease |
Positive |
p < 0.05; 61% inhibition |
13 |
| Nitrofurantoin |
50 μM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used glutamate as substrate |
decrease |
Positive |
p < 0.05; 72% inhibition |
13 |
| Nitrofurantoin |
5 μM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used glutamate as substrate |
decrease |
Positive |
p < 0.05; 38% inhibition |
13 |
| Nitrofurantoin |
1 mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used β-hydroxybutyrate as substrate |
decrease |
Positive |
p < 0.05 |
13 |
| Nitrofurantoin |
50 μM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used β-hydroxybutyrate as substrate |
decrease |
Positive |
p < 0.05; 60% inhibition |
13 |
| Nitrofurantoin |
5 μM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used β-hydroxybutyrate as substrate |
decrease |
Positive |
p < 0.05 |
13 |
| Nitrofurantoin |
1 mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used α-ketoghttarate as substrate |
decrease |
Positive |
p < 0.05 |
13 |
| Nitrofurantoin |
50 μM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used α-ketoghttarate as substrate |
decrease |
Positive |
p < 0.05; 70% inhibition |
13 |
| Nitrofurantoin |
5 μM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake; used α-ketoghttarate as substrate |
decrease |
Positive |
p < 0.05 |
13 |
| nitrofurazone |
1mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05; 64% inhibition |
13 |
| nitrofurazone |
1mM |
|
mouse; C57B/6J |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05; 63% inhibition |
13 |
| Perhexiline |
100 μM |
5 minutes preincubation |
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05 |
193 |
| Perhexiline |
400 μM |
5 minutes preincubation |
mouse; Crl/CD-l(1CR)BR Swiss |
liver mitochondria |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.01 |
193 |
| nitrofurazone |
5μM |
|
mouse; C57B/6J |
mitoplasts |
Measurement of oxygen uptake |
decrease |
Positive |
p < 0.05 |
13 |
| buformin |
100 nmol/mg mitochondrial protein |
|
rat; Sprague–Dawley |
liver mitochondria |
Meassurement of respiration |
decrease |
Positive |
|
15 |
| Phenformin |
100 nmol/mg mitochondrial protein |
|
rat; Sprague–Dawley |
liver mitochondria |
Meassurement of respiration |
decrease |
Positive |
|
15 |
| Metformin |
500 nmol/mg mitochondrial protein |
40 min preincubation |
rat; Sprague–Dawley |
liver mitochondria |
Meassurement of respiration |
decrease |
Positive |
|
15 |
| buformin |
100 nmol/mg mitochondrial protein |
40 min preincubation |
rat; Sprague–Dawley |
liver mitochondria |
Meassurement of respiration |
decrease |
Positive |
|
15 |
| Phenformin |
100 nmol/mg mitochondrial protein |
40 min preincubation |
rat; Sprague–Dawley |
liver mitochondria |
Meassurement of respiration |
decrease |
Positive |
|
15 |
| Ketoconazole |
I50=32, 74, 65, 75, 500μM for substrates Glutamate/Malate, Pyruvate/Malate, Ornithine/Malate, Arginine/Malate and Succinate repectively |
|
rat |
liver mitochondria |
Clark electrode |
inhibit |
Positive |
|
303 |